A Study of Lurasidone Compared With Placebo for the Treatment of Bipolar I Depression
Clinical trial NCT04383691 · TERMINATED
Trial details
- NCT number
- NCT04383691
- Sponsor
- Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-11
- Primary completion
- 2022-12-23
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.